SARS-CoV-2 Infected Human Lung Cell Systems with Arbutus Biopharma Corp

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/2111/15/23

Funding

  • Arbutus Biopharma Inc: $280,325.00